A bispecific antibody (BsAb) is a type of artificial protein with the ability to bind to two distinct antigens or two epitopes of one antigen at the same time. Bispecific antibodies can assume a ...
Zenocutuzumab is a first-in-class, humanized, full-length immunoglobulin G1 bispecific antibody that targets HER2 and HER3 directly. After docking on HER2, the drug blocks HER2-HER3 dimerization and ...
The Swiss biopharmaceutical company Light Chain Bioscience has developed a novel and unique class of human, bispecific antibodies dubbed ... is an immune checkpoint protein that functions as ...
Bispecific antibodies (bsAbs) utilize the properties ... CD3E & CD3D CDD-H5255 HEK293 Human CD3 epsilon&CD3 delta Heterodimer Protein, Fc Tag&Fc Tag (MALS verified) New CDD-H52Wa HEK293 Human ...
From its inception in 2015, the company has been focused exclusively on discovering and developing innovative biologics, including monoclonal antibodies (mAbs), fusion proteins and bispecific ...
Experts said a certain type of bispecific antibody seems to have hit upon a crucial combination of two cancer targets: the proteins VEGF and either PD-1 or PD-L1. “It’s exactly that,” said ...
The poster titled “ Preclinical and Translational Pharmacokinetics of GD2-SADA, a Self-Assembling and Disassembling (SADA) Bispecific Fusion Protein for Pretargeted Radioimmunotherapy (PRIT)” ...
Kexing Biopharm Co. Ltd. has outlined progress in its cachexia and autoimmune pipelines, built upon its Kx-Body antibody technology platform and Kx-Fusion fusion protein technology platform.
Biocytogen (HKEX: 02315) and Acepodia (6976:TT), today announced a groundbreaking strategic partnership to jointly assess a dual-payload bispecific antibody-drug conjugate (BsAD2C) program.
Investment company RTW Investments has launched a new biotech company called Prolium Bioscience, to advance the development of ICP-B02, a CD20×CD3 bispecific antibody originating from China’s ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果